AptarGroup, Inc. Q1 2009 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for AptarGroup, Inc., a manufacturer of consumer product dispensing systems, for the period ended March 31, 2009. The company operates in three segments: Beauty & Home, Closures, and Pharma. The reporting period reflects the impact of a strengthening U.S. dollar against the Euro and a global economic downturn affecting consumer demand.
Key Financial Metrics
| Metric (in thousands) | Q1 2009 | Q1 2008 |
|---|---|---|
| Net Sales | $431,816 | $532,258 |
| Operating Income | $39,306 | $54,699 |
| Net Income (Attributable to AptarGroup) | $26,665 | $36,901 |
| Diluted EPS | $0.38 | $0.52 |
| Operating Margin | 9.1% | 10.3% |
| Cash and Equivalents | $203,882 | $335,216 |
| Total Debt (Short + Long Term) | $304,674 | $291,507 |
| Net Cash Provided by Operations | $48,777 | $38,978 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 19% year-over-year. Approximately 10% of this decline was attributed to the strengthening U.S. dollar, while the remainder was due to lower product volumes and custom tooling sales.
- Profitability Pressure: Operating income fell 28% to $39.3 million. The Beauty & Home segment was the most impacted, with segment income dropping 64% due to volume reductions and underutilized overhead.
- Cost Management: Cost of sales as a percentage of net sales improved to 67.1% (from 68.1%) due to lower raw material costs (plastic resin) and a favorable segment mix shift toward the higher-margin Pharma segment.
- Cash Flow: Operating cash flow increased to $48.8 million, driven by working capital improvements, despite lower net income.
Outlook, Risks, and Management Commentary
- Guidance: Management expects diluted earnings per share for Q2 2009 to range between $0.37 and $0.42, compared to $0.64 in the prior year. This excludes the impact of a new facility consolidation plan.
- Facility Consolidation: In April 2009, the company announced a plan to consolidate two French manufacturing facilities and several sales offices. Estimated costs are $6 million, with expected annual savings of $3 million starting in 2010.
- Market Risks: Primary risks include continued global economic weakness, significant fluctuations in foreign currency exchange rates (specifically the Euro), and the ability to pass on raw material cost changes to customers.
- Liquidity: The company maintains a strong balance sheet with a Net Debt to Net Capital ratio of 8%. It has the capacity to borrow approximately $1.0 billion before exceeding its debt-to-capital covenant of 55%.
Investor Verification Checklist
- Currency Impact: Verify the extent to which the strengthening U.S. dollar continues to negatively impact reported sales and earnings in subsequent quarters.
- Volume Trends: Monitor the Beauty & Home segment specifically for signs of volume stabilization, as this segment drove the majority of the income decline.
- Cost Pass-Through: Assess whether the company can maintain the improved cost of sales percentage as raw material prices fluctuate and customer demand remains soft.
- Capital Expenditures: Confirm if the estimated $130 million in 2009 capital expenditures will be maintained or reduced in response to the economic environment.
- Consolidation Execution: Track the timing and cost realization of the announced facility consolidation plan to ensure projected savings are achieved.